Evidence map›Paper›PMID 18809398›Full record

ArticleExperimental eye research2009

Temporal changes in MMP mRNA expression in the lens epithelium during anterior subcapsular cataract formation.

Zahra Nathu, Dhruva J Dwivedi, John R Reddan, Heather Sheardown, Peter J Margetts, Judith A West-Mays

Abstract read
In one paragraph

Article in Experimental eye research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. HPV16-E6 Oncoprotein Activates TGF-BioMed research international · 2018
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Zahra NathuDepartment of Pathology and Molecular Medicine, McMaster University, Health Sciences Centre, Hamilton, ON, Canada.
Dhruva J Dwivedi
John R Reddan
Heather Sheardown
Peter J Margetts
Judith A West-Mays
McMaster University · CAHealth Sciences Centre · CAOakland University · US

Funding

Role of MMPs in TGFbeta-induced Cataract FormationR01EY017146 · NEI · MCMASTER UNIVERSITY · PI WEST-MAYS, JUDITH A · 2006 to 2015
$2.2M
Matrix Metalloproteinases-Subcapsular Cataract FormationR03EY013845 · NEI · TUFTS MEDICAL CENTER · PI WEST-MAYS, JUDITH A · 2001 to 2002
$316k
Matrix Metalloproteinases-Subcapsular Cataract FormationR03EY015006 · NEI · MCMASTER UNIVERSITY · PI WEST-MAYS, JUDITH A · 2003 to 2004
$157k
NEI NIH HHS EY015006-01NEI NIH HHS R01 EY017146NEI NIH HHS R03 EY013845NEI NIH HHS R03 EY015006
6 · The paper itself

Abstract

Transforming growth factor beta (TGFbeta) has been known to play a role in anterior subcapsular cataract (ASC) formation and posterior capsule opacification (PCO), both of which are fibrotic pathologies of the lens. Several models have been utilized to study ASC formation, including the TGFbeta1 transgenic mouse model and the ex-vivo rat lens model. A distinct characteristic of ASC development within these models includes the formation of isolated fibrotic plaques or opacities which form beneath the lens capsule. A hallmark feature of ASC formation is the epithelial to mesenchymal transition (EMT) of lens epithelial cells (LECs) into myofibroblasts. Recently, the matrix metalloproteinases (MMPs) have been implicated in the formation of these cataracts through their involvement in EMT. In the present study, we sought to further investigate the role of MMPs in subcapsular cataract formation in a time course manner, through the examination of gene expression and morphological changes which occur during this process. RT-QPCR and immunohistochemical analysis was carried out on lenses treated with TGFbeta for a period of 2, 4 and 6 days. Laser capture microdissection (LCM) was utilized to specifically isolate cells within the plaque region and cells from the adjacent epithelium in lenses treated for a 6 day period. Multilayering of LECs was observed as early as day 2, which preceded the presence of alpha smooth muscle actin (alpha-SMA) immunoreactivity that was evident following 4 days of treatment with TGFbeta. A slight reduction in E-cadherin mRNA was detected at day 2, although this was not significant until the day 4 time point. Importantly, our results also indicate an early induction of MMP-9 mRNA following 2 days of TGFbeta treatment, whereas MMP-2 was found to be upregulated at the later 4 day time point. Further experiments using FHL 124 cells show an induction in MMP-2 protein levels following treatment with recombinant MMP-9. Together these findings suggest an upstream role for MMP-9 in ASC formation.

Indexed as

ActinsAnimalsCadherinsCataractCell LineCell ProliferationEpithelial CellsHumansImmunohistochemistryLens Capsule, CrystallineMaleMatrix Metalloproteinase 2Matrix Metalloproteinase 9Matrix MetalloproteinasesMicrodissectionModels, AnimalActinsCadherinsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Matrix MetalloproteinasesRecombinant ProteinsRNA, MessengerTransforming Growth Factor beta

Identifiers

PMID18809398
PMCPMC3408229
OpenAlexW1993138534

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.